The feud is heating up between the state and big pharmacy chains like CVS as Governor Jeff Landry unofficially calls for a ...

Like a solar flare suddenly erupting, in the last week of its session after little attention to the issue the Louisiana Legislature appears poised to enact significant and almost unprecedented ...

The new law imposes restrictions and regulations on pharmacy benefit managers, or PBMs, that negotiate prescription drug prices between manufacturers, health insurance companies and pharmacies.

Giving small-molecule drugs the same 13-year exemption from price negotiation as biologics would cost the federal government billions of dollars, argue three Harvard researchers ...

Federal agencies have scheduled a series of three web-based "listening sessions" to hear from commenters about issues that might be limiting competition in the U.S. prescription drug market and ...

AbCellera Biologics' drug candidates in Phase 1 trials show promise, but financial losses and slow progress raise concerns.

UroGen Pharma's FDA nod for UGN-102 fuels recovery, but cash burn raises financing risks. Check out why I am maintaining my ...

An exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers ...

Sanofi (NASDAQ: SNY) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Berenberg Bank analyst Luisa Hector ...

Independent Sens. Bernie Sanders of Vermont and Angus King of Maine have introduced a bill that would ban pharmaceutical ...

Gov. Josh Shapiro’s administration plans to save money by cutting poor patients’ access to expensive weight-loss drugs like ...

BATON ROUGE, La. (Louisiana Illuminator) - A low heat that’s simmered for weeks over an attempt to lower prescription drug ...